Is Prostamax FDA-approved?

No. Prostamax isn't FDA-approved, and Drugs@FDA lists no application with it as an active ingredient.

Checked 1 Nov 2026. The sources are below.

Prostamax

Also: Lys-Glu-Asp-Pro, KEDP, Prostomax

Status label in the Peptimes Library
Not FDA-Approved
Routes in Peptimes
SubcutaneousIntramuscularOralSublingualNasalTopicalOther
Updated
1 Nov 2026

US regulatory status

  • FDA status

    Not FDA-Approved. Drugs@FDA lists no application with Prostamax (Lys-Glu-Asp-Pro) as an active ingredient.

    Source: Drugs@FDA, checked 1 Nov 2026

What studies have looked at

Each point says who or what was studied and what the study reported, with its source and the date we checked it. These are findings from the sources cited, not advice or a promise of any result.

  • In animals or the lab

    In cells from people aged 75 to 86, Prostamax increased sister chromatid exchanges and active ribosomal-gene regions, which the authors read as a loosening of chromatin that condenses with age. A cell study only, published in Russian.

    Source: PMID 23221144, checked 1 Nov 2026

How to track it in Peptimes

Add Prostamax in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Not FDA-Approved”.

  • Routes: subcutaneous, intramuscular, oral, sublingual, nasal, topical or Other. Choose the one that matches each dose.
  • Logging: the amount you took, the route and how you feel.
  • Injection sites: subcutaneous and intramuscular doses record the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next. Other routes skip this step.
  • Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.

Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell Prostamax or any other compound.

More sources

  • US National Library of Medicine, MeSH, Prostamax, checked 1 Nov 2026: a supplementary substance record with the names H-Lys-Glu-Asp-Pro-OH and lysyl-glutamyl-aspartyl-proline, mapped to the heading Oligopeptides.
  • ClinicalTrials.gov, searched 1 Nov 2026: no registered study of Prostamax.

Coming soon to the App Store

Coming soon to Google Play

See planned pricing